A Study to Assess the Efficacy and Safety of Oxycodone/Naloxone in Korean Patients With Chemotherapy-Induced Peripheral Neuropathy (CIPN)

NCT01675531 · clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
73
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Mundipharma Korea Ltd